What are TCR therapies?

TCR therapies are a form of immunotherapy that harnesses the body's T-cells to recognize and attack HIV-infected cells, potentially leading to a cure.

How do TCR therapies differ from traditional HIV treatments?

Unlike traditional antiretroviral therapies that suppress the virus, TCR therapies aim to eliminate HIV-infected cells from the body.

What are the latest findings in TCR therapy research?

Recent studies have shown promising results in clinical trials, with some patients achieving sustained viral remission after TCR therapy.

Are there any risks associated with TCR therapies?

As with any immunotherapy, there are potential risks, including immune-related side effects and the possibility of cytokine release syndrome.

When can we expect TCR therapies to be widely available?

While TCR therapies are still in clinical trials, researchers are optimistic that they could become available within the next few years, pending regulatory approval.